Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 fold » _ fold (Expand Search), 5 fold (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 fold » _ fold (Expand Search), 5 fold (Expand Search)
-
19181
-
19182
S1 Data -
Published 2024“…The two groups of rats were observed and compared for PVT formation at 1, 3 and 5 days after modeling, respectively.</p><p>Results</p><p>A stable rat PVT model was successfully constructed. …”
-
19183
-
19184
-
19185
-
19186
-
19187
-
19188
-
19189
-
19190
-
19191
-
19192
-
19193
Image5_Investigating Effect of Coherent Emission Length on Pion Interferometry in High-Energy Collisions Using a Multiphase Transport Model.EPS
Published 2022“…<p>We study the two-pion Hanbury Brown–Twiss correlation functions for a partially coherent source constructed with the emission points and momenta of the identical pions generated by a multiphase transport model. …”
-
19194
-
19195
eGFR trajectories by type of physical activity.
Published 2025“…</p><p>Results</p><p>During 9.5 years of follow-up, the eGFR decreased by 0.97 ml/min/1.73m<sup>2</sup> per year. …”
-
19196
-
19197
-
19198
DataSheet1_Effect of CYP3A4 Inhibitors and Inducers on Pharmacokinetics and Pharmacodynamics of Saxagliptin and Active Metabolite M2 in Humans Using Physiological-Based Pharmacokin...
Published 2021“…The predictions also showed that although PK profiles of saxagliptin showed significant changes with delavirdine (AUC 1.5-fold increase) or rifampicin (AUC: a decrease to 0.19-fold) compared to those without inhibitors or inducers, occupancies of DPP-4 by saxagliptin were nearly unchanged, that is, the administration dose of saxagliptin need not adjust when there is coadministration with delavirdine or rifampicin.…”
-
19199
-
19200